| 10725051 |
Multiplex MRM assay for evaluation of cancer |
David B. Krizman, Sheeno Thyparambil, Wei-Li Liao |
2020-07-28 |
|
| 10722509 |
Predicting optimal chemotherapy for CRC |
Fabiola CECCHI |
2020-07-28 |
|
| 10722531 |
OPRT expression and cancer treatment outcome |
Fabiola CECCHI, Dongyao YAN |
2020-07-28 |
|
| 10725045 |
Quantifying MGMT protein for optimal cancer therapy of glioblastoma |
Fabiola CECCHI, Dongyao YAN |
2020-07-28 |
|
| 10718780 |
SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein |
David B. Krizman, Adele Blackler, Wei-Li Liao |
2020-07-21 |
|
| 10620223 |
SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein |
David B. Krizman, Sheeno Thyparambil, Wei-Li Liao |
2020-04-14 |
|
| 10617717 |
Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy |
Fabiola CECCHI, Jean-Charles Soria |
2020-04-14 |
|
| 10620184 |
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein |
David B. Krizman, Eunkyung An |
2020-04-14 |
|
| 10585099 |
SRM/MRM assays for cancer |
Fabiola CECCHI, Sarit SCHWARTZ, Kerry SCOTT |
2020-03-10 |
|
| 10537576 |
Methods for treating Her2-positive breast cancer |
Adele Blackler, Fabiola CECCHI, Paolo Nuciforo |
2020-01-21 |
|
| 10302656 |
CMET protein SRM/MRM assay |
David B. Krizman, Sheeno Thyparambil |
2019-05-28 |
|
| 10288616 |
Quantifying met protein for cancer treatment |
Daniel CATENACCI, Fabiola CECCHI, Wei-Li Liao |
2019-05-14 |
|
| 10215761 |
Bcl-2-like protein 11 SRM/MRM assay |
David B. Krizman, Sheeno Thyparambil, Wei-Li Liao |
2019-02-26 |
|
| 10208130 |
Quantifying Her2 protein for optimal cancer therapy |
Yung-Jue Bang, Eunkyung An, Do-Youn Oh |
2019-02-19 |
|
| 10202635 |
SRM/MRM assay for the ephrin type-A receptor 2 protein |
David B. Krizman, Wei-Li Liao, Sheeno Thyparambil |
2019-02-12 |
|
| 10203336 |
SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) protein |
David B. Krizman, Adele Blackler, Wei-Li Liao |
2019-02-12 |
|
| 10126307 |
SRM/MRM assay for the androgen receptor (AR) protein |
David B. Krizman, Sheeno Thyparambil, Eunkyung An |
2018-11-13 |
|
| 10101334 |
Multiplex MRM assay for evaluation of cancer |
David B. Krizman, Sheeno Thyparambil, Wei-Li Liao |
2018-10-16 |
|
| 10078084 |
SRM/MRM assay for the mesothelin (MSLN) protein |
David B. Krizman, Eunkyung An, Sheeno Thyparambil |
2018-09-18 |
|
| 10073075 |
SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein |
David B. Krizman, Eunkyung An |
2018-09-11 |
|
| 10060927 |
SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein |
David B. Krizman, Eunkyung An, Sheeno Thyparambil, Wei-Li Lao |
2018-08-28 |
|
| 10054592 |
Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay |
David B. Krizman, Sheeno Thyparambil |
2018-08-21 |
|
| 10041961 |
SRM/MRM assay for the insulin receptor protein |
David B. Krizman, Wei-Li Liao, Sheeno Thyparambil |
2018-08-07 |
|
| 9869680 |
HER3 protein SRM/MRM assay |
David B. Krizman, Sheeno Thyparambil |
2018-01-16 |
|
| 9840728 |
SRM assay to indicate cancer therapy |
David B. Krizman, Sheeno Thyparambil, Wei-Li Liao |
2017-12-12 |
|